================================================================================
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
----------
FORM 8-K
----------
Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act
of 1934
Date of Report (date of earliest event reported): June 12, 1996
PhyMatrix Corp.
---------------------------------------------------------
(Exact name of registrant as specified in its charter)
<TABLE>
<CAPTION>
Delaware 0-27568 65-0617076
- ------------------------------ ---------------------- ---------------------------------
<S> <C> <C>
State or other jurisdiction of Commission File Number IRS Employer Identification No.
incorporation
</TABLE>
777 South Flagler Drive
West Palm Beach, FL 33401
----------------------------------------
(Address of principal executive offices)
(407) 655-3500
-------------------------------
(Registrant's telephone number,
including area code)
===============================================================================
<PAGE>
Item 5. Other Events.
On June 12, 1996, the following press release was issued in connection
with PhyMatrix Corp.'s proposed issuance of convertible subordinated debentures:
"West Palm Beach, FL -- June 12, 1996 -- PhyMatrix Corporation (Nasdaq:
PHMX), a physician practice management company, today announced that it
intends, subject to market and other conditions, to raise $100 million
through the sale of convertible subordinated debentures to certain
qualified institutional investors and non-U.S. persons and up to an
additional $15 million if an over-allotment option to be granted is
exercised in full. The debentures will be convertible into PhyMatrix Corp.
Common Stock.
The securities to be offered will not be registered under the Securities
Act of 1933, as amended, or applicable state securities laws, and may not
be offered or sold absent registration under the Securities Act and
applicable state securities laws or available exemptions from
registrations.
Headquartered in West Palm Beach, Florida, PhyMatrix, a physician practice
management company, provides management services to disease specialty and
primary care physicians, and provides related medical support services.
The Company's primary strategy is to develop disease management networks
in specific geographic locations by affiliating with disease specialty and
primary care physicians. Where appropriate, the Company supports its
affiliated physicians with related diagnostic and therapeutic medical
support services as well as medical malls or health parks."
* * *
<PAGE>
Signature
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
PHYMATRIX CORP.
By: /s/ Frederick R. Leathers
---------------------------------
Frederick R. Leathers
Chief Financial Officer and
Treasurer
Dated: June 18, 1996
